Citation Impact
Citing Papers
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
2013
Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
2013
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
2019
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
2011
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Acromegaly
2006 Standout
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
The Cardiovascular Biology of Glucagon-like Peptide-1
2016
Diabetic retinopathy
2010 Standout
Differential Roles of Hyperglycemia and Hypoinsulinemia in Diabetes Induced Retinal Cell Death: Evidence for Retinal Insulin Resistance
2011
Inflammation and metabolic disorders
2006 StandoutNature
Complementing Insulin Therapy to Achieve Glycemic Control
2013
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
Impact of obesity on treatment of chronic hepatitis C†
2006
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
2009
Age-Related Macular Degeneration
2008 Standout
Obesity and hypomagnesemia
2016
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Hallmarks of aging: An expanding universe
2023 Standout
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
2002 StandoutNobel
Involvement of circadian clock gene Clock in diabetes‐induced circadian augmentation of plasminogen activator inhibitor‐1 (PAI‐1) expression in the mouse heart
2005
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
2019
Efficacy of Anti Hyperglycemic Therapies and the Influence of Baseline Hemoglobin A1C: A Meta-Analysis of the Liraglutide Development Program
2011
Interferon alpha—a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity
2004
Effects of iron overload on chronic metabolic diseases
2014
Diabetic Retinopathy
2012 Standout
Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy?
2013
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045
2021 Standout
Liraglutide for the Treatment of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-Controlled Trials
2014
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
2003
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Type 2 diabetes
2017 Standout
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C
2007
Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women
2010
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Network biology concepts in complex disease comorbidities
2016
Guidelines on Diabetic Eye Care
2018
Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients
2004
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
2003
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies
2009
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Stimulation and Inhibition of Angiogenesis in Diabetic Retinopathy
2001
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer
2014
Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy
2008
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
2013
Quantitating Hemodialysis: A Comparison of Three Kinetic Models
1991
Somatostatin analogues as therapeutics in retinal disease
2009
The Urea Reduction Ratio and Serum Albumin Concentration as Predictors of Mortality in Patients Undergoing Hemodialysis
1993 Standout
Novel Targets Against Retinal Angiogenesis in Diabetic Retinopathy
2012
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women
2004
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases
2010
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial
2019
Cardiovascular Effects of Glucagonlike peptide–1 Agonists
2011
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
2021
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Regulation of Autophagy by High Glucose in Human Retinal Pigment Epithelium
2014
Combinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription Factors
2008
Ocular delivery of proteins and peptides: Challenges and novel formulation approaches
2018
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Anemia of Chronic Disease
2005 Standout
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
2017
CLOCK deubiquitylation by USP8 inhibits CLK/CYC transcription in Drosophila
2012 StandoutNobel
Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
2012
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Adenoviral Vector-Delivered Pigment Epithelium-Derived Factor for Neovascular Age-Related Macular Degeneration: Results of a Phase I Clinical Trial
2006
Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
2018
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program
2012
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Sex‐ and strain‐specific effects of mitochondrial uncoupling on age‐related metabolic diseases in high‐fat diet‐fed mice
2022
Peroxisome Proliferator-Activated Receptor-β/δ Regulates Angiogenic Cell Behaviors and Oxygen-Induced Retinopathy
2013
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies
2014
Proteome of Skeletal Muscle Lipid Droplet Reveals Association with Mitochondria and Apolipoprotein A-I
2011
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
2008 StandoutNobel
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Are Individuals With Diabetes Seeing Better?
2010
Current Issues in Measurement and Reporting of Urinary Albumin Excretion
2008
Intravitreal Injection of Erythropoietin Protects both Retinal Vascular and Neuronal Cells in Early Diabetes
2008
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Characterization of the Vitreous Proteome in Diabetes without Diabetic Retinopathy and Diabetes with Proliferative Diabetic Retinopathy
2008
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
2012
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
1999
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
2019
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Iron-Deficiency Anemia
2015 Standout
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2011
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
2022
Proresolution Therapy for the Treatment of Delayed Healing of Diabetic Wounds
2012
The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
2020 Standout
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2002
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
2013
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
2019
Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus
2014
Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators
2008
Works of Rafael Simó being referenced
Factors accounting for high ferritin levels in obesity
2008
Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy
2012
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
2008
Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy
2011
Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma
2007
Apolipoprotein A1 Is Overexpressed in the Retina of Diabetic Patients
2008
Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
2006
Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
2013
Glucose Abnormalities Are an Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C
2007
Relationship Between Lipoprotein(a) Phenotypes and Plaminogen Activator Inhibitor Type 1 in Diabetic Patients
2000
Iron in obesity. An ancient micronutrient for a modern disease
2009
Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
1997
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
2017
Diabetic macular oedema
2016
Phagocytic Activity Is Impaired in Type 2 Diabetes Mellitus and Increases after Metabolic Improvement
2011
Elevation of Apolipoprotein A-I and Apolipoprotein H Levels in the Vitreous Fluid and Overexpression in the Retina of Diabetic Patients
2008
Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives
2014
Diabetes Is the Main Factor Accounting for Hypomagnesemia in Obese Subjects
2012
Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice
2007
Obesity induced by high fat diet attenuates postinfarct myocardial remodeling and dysfunction in adult B6D2F1 mice
2015
The progress in understanding and treatment of diabetic retinopathy
2015
Vascular endothelial growth factor and diabetic complications
2008
Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects
2011
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial
2012
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
2015
Relación entre los depósitos de hierro y la diabetes mellitus en pacientes infectados por el virus de la hepatitis C: estudio de casos y controles
2000
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
2009
Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy
2007
Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: Effect of treatment with interferon
2001
Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes
2015
Glucose Abnormalities in Patients with Hepatitis C Virus Infection
2006
High Prevalence of Hepatitis C Virus Infection in Diabetic Patients
1996
geoRge: A Computational Tool To Detect the Presence of Stable Isotope Labeling in LC/MS-Based Untargeted Metabolomics
2015
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
2017
Why dialyze more than 6 hours a week?
1985
Expression of Erythropoietin and Its Receptor in the Human Retina
2008
Erythropoietin Is Expressed in the Human Retina and It Is Highly Elevated in the Vitreous Fluid of Patients With Diabetic Macular Edema
2006
Advances in the Medical Treatment of Diabetic Retinopathy
2009
Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation.
2008
Albumin Excretion Rate Is Not Affected by Asymptomatic Urinary Tract Infection
2004
High Prevalence of Glucose Abnormalities in Patients With Hepatitis C Virus Infection
2004
Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy
2004
The Retinal Pigment Epithelium: Something More than a Constituent of the Blood-Retinal Barrier—Implications for the Pathogenesis of Diabetic Retinopathy
2010
Lower Somatostatin Expression Is an Early Event in Diabetic Retinopathy and Is Associated With Retinal Neurodegeneration
2007
Deficit of Somatostatin-Like Immunoreactivity in the Vitreous Fluid of Diabetic Patients
2002
Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection
2006
Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy
2014
Diabetic retinopathy
2016
Iron Overload in Diabetic Retinopathy: A Cause or a Consequence of Impaired Mechanisms?
2010
Deficit of Somatostatin in the Vitreous Fluid of Patients With Diabetic Macular Edema
2007
Topical Administration of Somatostatin Prevents Retinal Neurodegeneration in Experimental Diabetes
2013
Calorie restriction prevents diet‐induced insulin resistance independently of PGC‐1‐driven mitochondrial biogenesis in white adipose tissue
2018
Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
2000